D48.62
Neoplasm of uncertain behavior of left breast
Clinical Classification Guidelines
Medical Intelligence & Overview
A neoplasm of uncertain behavior of the left breast, classified under ICD-10 code D48.62, refers to an abnormal growth in the breast tissue that has features between benign (non-cancerous) and malignant (cancerous) tumors. This designation indicates that medical professionals are uncertain about whether the growth will develop into cancer, warranting careful evaluation and monitoring. It is essential to understand that this diagnosis does not confirm cancer but highlights the need for further assessment to determine the nature of the growth.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to abnormal cell growth Hormonal imbalances affecting breast tissue development Previous benign breast conditions that have changed or progressed Environmental exposures or lifestyle factors potentially influencing cell behavior Age-related changes in breast tissue Unknown factors that still require research for clarification
Key Symptoms: Lump or mass in the breast that may be felt easily or only during imaging tests Changes in the size, shape, or feel of the breast Skin changes on the breast, such as dimpling or redness Nipple alterations, including inversion or discharge Persistent pain or discomfort in the breast or underlying tissues Unexplained swelling in the breast or nearby lymph nodes
Diagnostic & Treatment
Diagnosis Path: The process of diagnosing a neoplasm of uncertain behavior involves multiple steps:
Treatment Protocols: Management strategies depend on the characteristics and findings associated with the neoplasm:
Clinical Advice & FAQs
Billing Guidance
Is D48.62 a billable ICD-10 code?
Yes, D48.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D48.62?
Clinical documentation must specify the nature of Neoplasm of uncertain behavior of left breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference